Product details
The BD Veritor™ System for Rapid Detection of Group A Strep is designed to deliver fast, accurate identification of Group A Streptococcus at the point of care. Manufactured by BD, this system supports prompt clinical decision-making for patients presenting with sore throat and related symptoms.
Using digital immunoassay technology, the BD Veritor™ System provides clear, objective results that help reduce subjectivity associated with visually read tests. The rapid turnaround time enables clinicians to quickly determine appropriate treatment, helping improve patient outcomes and antibiotic stewardship.
The CLIA-waived format allows testing to be performed in physician offices, urgent care centers, clinics, and other near-patient settings without the need for complex laboratory infrastructure.
Key Features:
-
Rapid detection of Group A Streptococcus
-
CLIA-waived for point-of-care testing
-
Digital immunoassay technology for objective result interpretation
-
Fast turnaround supports timely treatment decisions
-
Helps improve workflow efficiency in clinical settings
-
Suitable for physician offices, urgent care, and outpatient clinics
